<DOC>
	<DOCNO>NCT02075957</DOCNO>
	<brief_summary>Description new transcriptional profile associate risk relapse identification specific sit relapse non-small cell lung cancer , toxicity resistance adjuvant chemotherapy completely resect non-small cell lung cancer ( NSCLC ) .</brief_summary>
	<brief_title>Identification Microarrays Risks Metastatic Relapse , Toxicity Resistance Adjuvant Chemotherapy Completely Resected Non-small Cell Lung Cancer</brief_title>
	<detailed_description>- A first blood sample take week operation . A second blood sample take 4 8 week operation . And case relapse , third sample take . These sample go stored collection biological resource Angers . - Concerning biopsy resect NSLCL , send collection biological resource Angers conservation directly next surgery .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Major subject Subject receive resection primary nonsmall cell lung cancer University Hospital Angers whose tumor sample store collection biological resource University Hospital Angers A write inform consent . Under 18 year old ; Pregnant nursing woman ; Deprived liberty ; Age curatorship guardianship ; Unable consent person ; About carry nonsmall cell lung cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Non-small cell lung cancer , adjuvant chemo-therapy , DNA chip</keyword>
</DOC>